United States Antihypertensive Prescription Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Antihypertensive Prescription Markets, Executive SummaryIntroduction to the U.S. Antihypertensive Prescription MarketObjectives and PurposeMarket Definition Summary of Major FindingsMarket Growth, Opportunities, and Total ForecastAnalysis by Major SegmentCompetitive AnalysisTechnologiesConclusionsUnited States Antihypertensive Prescription Markets, Market Engineering Research MethodologyResearch ScopeObjectives and PurposeReport Structure and Market SegmentationMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsGlossary of TermsList of AcronymsUnited States Antihypertensive Prescription Markets, Industry ChallengesIdentification of Challenges Facing the U.S. Antihypertensive Prescription MarketIdentification of Challenges Facing the U.S. Antihypertensive Prescription MarketPatient Noncompliance Minimizes the Benefits of Antihypertensive TreatmentsThe Lack of a One-Size-Fits-All Pharmacotherapy Hinders Widespread Acceptance of Managed Care Organizations and PhysiciansBroad Range of Treatment Options Places a Tyranny of Choice on End-UsersLack of Understanding of Antihypertensive Treatment Strategy Increases Rates of Noncompliance and Uncontrolled HypertensionAntihypertensive Marketplace Suffers from the Introduction of Generics, Leading to Pressures on Pricing and Market Penetration RatesThought Leaders in Cardiology Influence Largest Antihypertensive Prescribing ForceManufacturers Fail to Persuade Physicians of the Benefits of Aggressive TreatmentPatients That Do Not Modify Dietary and Exercise Habits Do Not Reap the Full Benefits of Antihypertensive MedicationThe Use of the Internet Provides Opportunities to Educate Physicians and ConsumersClinical Data Does Not Address Dosing Concerns of Antihypertensive AgentsJoint National Committee (JNC) Guidelines Educate Physicians on Treatment Options for the Hypertensive PatientGenomic Advances Lead to a Revolution in the Management of Blood Pressure ControlMarket Engineering Research for the U.S. Antihypertensive Prescription Market 1996-2006Total Market Overview and DefinitionsTotal Market Overview and DefinitionsScope & SegmentationApproaches to Blood Pressure ControlThe Sixth Joint National Committee (JNC-VI) GuidelinesMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Market DriversMarket RestraintsMarket ForecastsOther Market and Technology TrendsPricing TrendsTrends by End-UserTechnology trendsCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyMarket Share Winners and WhyMarket Share Losers and WhyMarket Share TrendsProduct AnalysisMarket Engineering Research for the U.S. Calcium Channel Blocker Antihypertensive Prescription Market 1996-2006Market Overview and DefinitionsMarket Overview and DefinitionsScope/SegmentationMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Market DriversMarket RestraintsMarket Forecast Other Market TrendsPricing and Trend AnalysisPricing and Trend AnalysisCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyMarket Share Winners and WhyMarket Share Losers and WhyMarket Share TrendsCompetitive Advantage of the CCB Class Product AnalysisProduct AnalysisMarket Engineering Research for the U.S. Angiotensin Converting Enzyme Inhibitor Antihypertensive Prescription Market 1996-2006Market Overview and DefinitionsMarket Overview and DefinitionsScope/SegmentationMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Market DriversMarket RestraintsMarket ForecastPricing and Trend AnalysisPricing and Trend AnalysisCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyMarket Share Winners and WhyMarket Share Losers and WhyMarket Share TrendsProduct AnalysisProducts on the MarketProducts in Clinical TrialsMarket Engineering Research for the U.S. Angiotensin Receptor Blocker Antihypertensive Prescription Market 1996-2006Market Overview and DefinitionsMarket Overview and DefinitionsScope/SegmentationMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Market DriversMarket RestraintsMarket Forecast Other Market and Technology TrendsPricing and Trend AnalysisPricing and Trend AnalysisCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyMarket Share Winners and WhyMarket Share Losers and WhyMarket Share TrendsProduct AnalysisProducts on the MarketProducts in Clinical TrialsUnited States Antihypertensive Prescription Markets, Market Engineering StrategyMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsBusiness Development and Corporate Management:SalesMarketingResearch and DevelopmentMarket Engineering Awards for the U.S. Antihypertensive Prescription MarketFrost & Sullivan's 2000 Market Engineering AwardsFrost & Sullivan's 2000 Market Engineering AwardsMarket Engineering AwardsMarket Engineering AwardsAward Category: Market LeadershipAward Category: Brand Awareness DevelopmentAward Category: Customer Service Leadership Award Category: Market Penetration




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.